January 14, 2019

2019 Medicare final payment rule brings big wins for ASCs

By: Janet M. Boivin, BSN, BSJ, RN
Share

The holiday spirit got off to a good start at ambulatory surgery centers (ASCs) across the country with the November 2, 2018, announcement of the Centers for Medicare & Medicaid Services’ (CMS) 2019 Ambulatory Surgical Center Payment System and Quality Reporting (ASCQR) Program Final Rule. Several significant changes ASCs had long lobbied for were included in the final rule.

The most beneficial change was CMS’s decision to base its annual inflation update for ASC payments on the hospital market basket and not the Consumer Price Index for All Urban Consumers (CPI-U).

“This change will help to promote ‘site neutrality’ between hospitals and ASCs and encourage the migration of services from the hospital setting to the lower-cost ASC setting,” CMS said when it announced the final rule on its website.

“The changes included in this year’s rule are among the most significant I have seen in my 8 years with ASCA,” says William Prentice, chief executive officer of the Ambulatory Surgery Center Association (ASCA). “We have fought for this change [to the market basket] over the last decade and appreciate that it was adopted. It is a more realistic indicator of rising costs in the ASC space.”

 

Leveling the playing field

ASCs were the only brick-and-mortar healthcare facilities to receive inflation rates based on the CPI-U, even though ASCs use the same staff, services, and supplies as hospital outpatient departments (HOPDs), according to Kara Marshall Newbury, ASCA regulatory counsel.

Kara Marshall Newbury

“This decision will slow the growing disparity between ASC and HOPD payment rates,” she says.

“This is the first time [CMS] has given us a significant boost,” notes Jeffrey Flynn, CASC, chief executive officer (CEO) of Gramercy Surgery Center in New York City. “It is well overdue. Medicare now seems to be well in tune—as many commercial payers already are—that from standpoints such as infection control and efficiency, ASCs are usually a better choice than an HOPD.”

The change to the market basket means that, for 2019, ASC reimbursements for all covered procedures will see on average an update of 2.1%. Updates will vary depending on specialty and coding.

“The change is based on the hospital market basket increase of 2.9% minus a 0.8 percentage point adjustment for MFP [multifactor productivity],” according to CMS.

ASCs must prove during the next 5 years that this change will result in a migration of procedures from HOPDs to ASCs, leading to savings for CMS and patients without a worsening of patient outcomes or satisfaction, Prentice says. Medicare is asking ASCs to help collect and report data regarding migration and savings.

“I think Medicare, by giving us a nice increase, enables us to perform more services for its beneficiaries and to possibly expand services as we look at efficiency and costs,” says Flynn, vice president of the New York State Association of Ambulatory Surgery Centers. For example, the state association is bringing independent centers together under one group purchasing organization to get better pricing, he notes.

For people over age 65, the change will offer options that will save on out-of-pocket costs. “The population is aging, and Medicare is becoming a larger payer,” says Andy Poole, CEO of Monticello Community Surgery Center in Charlottesville, Virginia.

And for ASCs, the benefit of the Medicare changes come from “not just the individual one-off rate increase, but from the volume that is also behind it. We’re seeing a continued growth of Medicare as a percentage of patients; add in the volume component of the increase, and it increases further in its significance,” Poole says.

 

More generous device coverage

More expensive devices, such as some implants, will be paid by Medicare now that CMS defines ASC device-intensive procedures as those with a device offset percentage greater than 30%, rather than the previous 40%.

This means that if a device needed to perform a procedure represents more than 30% of the cost of the overall procedure in an HOPD, Medicare will incorporate the full amount of the device in the payment rate for ASCs, explains Newbury.

The lower threshold expands the number of device-intensive procedures from 153 to 277 in 2019, making it economically viable for ASCs to perform more procedures with significant device costs.

Poole says his center performs many spinal procedures, some of which use nerve stimulators that are just above the 40% threshold. Now that the threshold has been lowered, there may be other options for surgeons.

 

More ASC-payable procedures

Jeffrey Flynn, CASC

CMS has finalized the addition of 12 cardiac catheterization procedures that were in the proposed rule now that it has revised the definition of surgery in the ASC payment system to account for certain surgery-like procedures assigned codes outside the CPT surgical range.

CMS is also adding five additional procedures performed during cardiac catheterization to the list of ASC covered surgical procedures.

Covered surgical procedures are those that are paid separately under the Outpatient Prospective Payment System, would not be expected to pose a significant risk to beneficiary safety, and would not typically be expected to require active medical monitoring and care at midnight following the procedure, according to CMS.

“Although these procedures are already being performed on patients who are not covered by Medicare, in 2019, we expect to see these procedures performed for the first time in Medicare beneficiaries in the ASC setting because of the changes,” Newbury says.

In addition, CMS’s review of a list of codes, including many spine codes currently performed in ASCs, found they can be done safely, effectively, and to the benefit of the Medicare patient. These procedures had been added to the ASC-payable list 3 years prior to the rule they were engaged in making during 2015 to 2017.

 

Payment for non-opioid pain management

When Exparel is used in procedures performed in an outpatient setting, CMS will pay for it separately. Exparel, the only non-opioid pain-relief injectable used during surgery as a local anesthetic or for a nerve block, is the only drug currently approved by the Food and Drug Administration for that purpose.

When other drugs similar to Exparel come on the market, they too will then be reimbursed.

This separate payment removes a disincentive to using non-opioid pain relievers, which aligns with healthcare providers’ and policy makers’ plans to reduce the use of opioids across the country.

 

Streamlined ASC quality reporting program

There were many changes to the ASCQR Program for 2019 and beyond that ASC administrators need to be aware of, Newbury says.

For example, CMS is removing certain measures from the ASCQR Program, according to the CMS website: “The removal of these measures is consistent with the CMS’s commitment to using a smaller set of more meaningful measures and focusing on patient-centered outcomes measures, while taking into account opportunities to reduce the paperwork and reporting burden on providers.”

Poole praises the reporting changes: “You don’t want to measure something that does not provide meaningful data. It is good to see Medicare adjust these measures over time as performance evolves.”

Overall, the final rule will eliminate a significant number of measures—a total of six that ASCs are currently required to report.

Although ASCs do not need to report on all the same quality measures as before, participation in the program is still required. ASCs that do not meet the 2019 reporting requirements will see reductions in their Medicare payments in the future, just as before.

 

What’s next?

Andy Poole

“In the short term, to make the most of the many changes the 2019 payment rule provides, ASCs need to look carefully at the procedures they perform and the impact of the new payment rates on their ASC’s bottom line,” Newbury says. To help with this process, ASCA members can access an online rate calculator.

Other resources available from ASCA include a webinar on quality reporting measures (https://asca.sclivelearningcenter.com/MVSite/MVSearch.aspx?keyword=CMS%20Quality%20Reporting%20for%20ASCs) and a list of frequently asked questions (https://www.ascassociation.org/federalregulations/qualityreporting/medicare-quality-reporting-faqs). ✥

 

Janet M. Boivin, BSN, BSJ, RN, is a freelance healthcare writer in the Boston area.

Join our community

Learn More
Video Spotlight
Live chat by BoldChat